А. В. Султанбаев

1.5k total citations
52 papers, 63 citations indexed

About

А. В. Султанбаев is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, А. В. Султанбаев has authored 52 papers receiving a total of 63 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 12 papers in Epidemiology. Recurrent topics in А. В. Султанбаев's work include BRCA gene mutations in cancer (9 papers), Advanced Breast Cancer Therapies (9 papers) and PARP inhibition in cancer therapy (8 papers). А. В. Султанбаев is often cited by papers focused on BRCA gene mutations in cancer (9 papers), Advanced Breast Cancer Therapies (9 papers) and PARP inhibition in cancer therapy (8 papers). А. В. Султанбаев collaborates with scholars based in Russia, Rwanda and Indonesia. А. В. Султанбаев's co-authors include А. А. Измайлов, С. П. Иванов, D.А. Kudlаy, Ozal Beylerli, Dina Sakaeva, Lyudmila Zhukova, Л. В. Болотина, Vagif Atduev, В. Б. Матвеев and Anastasia Mochalova and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

А. В. Султанбаев

31 papers receiving 61 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
А. В. Султанбаев Russia	4	30	16	14	13	13	52	63
Sam Khan United Kingdom	6	31 1.0×	19 1.2×	13 0.9×	25 1.9×	26 2.0×	18	96
Valentina Zanuso Italy	6	51 1.7×	19 1.2×	4 0.3×	20 1.5×	19 1.5×	16	93
Ana Santaballa Bertrán Spain	5	30 1.0×	15 0.9×	14 1.0×	18 1.4×	9 0.7×	11	81
Anghesom Ghebremedhin United States	5	35 1.2×	22 1.4×	9 0.6×	41 3.2×	20 1.5×	10	107
Karina Rønlund Denmark	5	20 0.7×	16 1.0×	12 0.9×	22 1.7×	22 1.7×	10	63
Kenneth Grossman United States	5	46 1.5×	7 0.4×	3 0.2×	30 2.3×	18 1.4×	8	108
Ramanan Kumareswaran United States	12	44 1.5×	27 1.7×	11 0.8×	43 3.3×	10 0.8×	40	322
M.P. Barretina Ginesta Spain	4	46 1.5×	9 0.6×	12 0.9×	17 1.3×	23 1.8×	19	123
Sandeep Kaul United Kingdom	5	28 0.9×	10 0.6×	15 1.1×	29 2.2×	13 1.0×	16	72
E.M. Guerra Spain	4	43 1.4×	11 0.7×	13 0.9×	26 2.0×	5 0.4×	8	77

Countries citing papers authored by А. В. Султанбаев

Since Specialization

Citations

This map shows the geographic impact of А. В. Султанбаев's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by А. В. Султанбаев with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites А. В. Султанбаев more than expected).

Fields of papers citing papers by А. В. Султанбаев

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by А. В. Султанбаев. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by А. В. Султанбаев. The network helps show where А. В. Султанбаев may publish in the future.

Co-authorship network of co-authors of А. В. Султанбаев

This figure shows the co-authorship network connecting the top 25 collaborators of А. В. Султанбаев. A scholar is included among the top collaborators of А. В. Султанбаев based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with А. В. Султанбаев. А. В. Султанбаев is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Султанбаев, А. В., et al.. (2024). Maintenance therapy with avelumab as the first-line treatment in patients with metastatic urothelial carcinoma: A real-world, ambispective RAVE-Bladder study.. Journal of Clinical Oncology. 42(16_suppl). e16569–e16569. 1 indexed citations

Султанбаев, А. В., et al.. (2024). Mechanisms of Formation of Specific Antitumor Immunity and Resistance to Immune Checkpoint Inhibitors. Voprosy Onkologii. 70(3). 433–439. 1 indexed citations

Султанбаев, А. В., et al.. (2024). Quantitative indicators of TREC and KREC excision circles in malignancies: a prospective cohort study. SHILAP Revista de lepidopterología. 26(2). 132–138.

Султанбаев, А. В., et al.. (2024). Palbociclib in real clinical practice: Results of a single-center observational study. Meditsinskiy sovet = Medical Council. 42–50.

Султанбаев, А. В., et al.. (2023). Treatment of Metastatic Renal Cell Carcinoma with Checkpoint Inhibitors inClinical Practice in the Volga-Ural Region of the Eurasian Continent. Current Pharmaceutical Design. 29(41). 3312–3323.

Султанбаев, А. В., et al.. (2023). Breast cancer screening in germline mutation carriers. A literature review. SHILAP Revista de lepidopterología. 19(2). 16–24. 1 indexed citations

Султанбаев, А. В., et al.. (2023). Predictors of Multiple Primary Malignancies: Literature Review. SHILAP Revista de lepidopterología. 13(3). 221–228.

Султанбаев, А. В., et al.. (2022). Hepatocellular Carcinoma: Aetiology and Mechanisms of Development. A Literature Review. SHILAP Revista de lepidopterología. 12(2). 139–150. 2 indexed citations

Султанбаев, А. В., et al.. (2022). Experience with olaparib in the treatment of BRCA-associated tumors in real clinical practice. Observational study. Journal of Modern Oncology. 24(2). 221–225. 1 indexed citations

10.

Султанбаев, А. В., et al.. (2022). Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma in Real Clinical Practice. SHILAP Revista de lepidopterología. 32(4). 75–88. 1 indexed citations

11.

Султанбаев, А. В., et al.. (2022). The mechanism of action of different generations of EGFR-inhibitors in malignant lung tumors. Literature review and data synthesis. SHILAP Revista de lepidopterología. 24(3). 340–344.

12.

Султанбаев, А. В., et al.. (2022). Immunotherapy of advanced hepatocellular carcinoma: case report and literature review. SHILAP Revista de lepidopterología. 31–39. 1 indexed citations

13.

Султанбаев, А. В., et al.. (2022). Prospects of PARP Inhibitors in Treatment of BRCA-Mutated Pancreatic Cancer: a Literature Review. SHILAP Revista de lepidopterología. 12(1). 48–55.

14.

Султанбаев, А. В., et al.. (2021). Renal cell carcinoma with metastases to the external genitalia. Literature review and case report. SHILAP Revista de lepidopterología. 17(2). 174–181.

15.

Султанбаев, А. В., et al.. (2021). Treatment of advanced small cell lung cancer. Clinical case and literature review. SHILAP Revista de lepidopterología. 23(1). 112–115.

16.

Султанбаев, А. В., et al.. (2020). Organization of screening for prostate cancer in carriers of germinal mutations in the BRCA1 / 2 genes. European Urology Open Science. 21. S59–S59. 3 indexed citations

17.

Султанбаев, А. В., et al.. (2020). Hereditary prostate cancer screening. European Urology Open Science. 21. S155–S155. 2 indexed citations

18.

Gilyazova, I. R., et al.. (2020). Spectrum and frequency of BRCA1, BRCA2, CHEK2, PALB2, RAD50 mutations in breast cancer patients in the Republic of Bashkortostan. Kazan medical journal. 101(5). 691–697. 1 indexed citations

19.

Султанбаев, А. В., et al.. (2020). Radiogenic Vaginal Angiosarcoma: a Clinical Case. SHILAP Revista de lepidopterología. 10(2). 143–148. 1 indexed citations

20.

Султанбаев, А. В., et al.. (2017). LOGISTICS OF LYMPHOGENIC BREAST CANCER METASTASIS. SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact